Life Sciences and Healthcare

Russia: Capricious or Compulsory Licensing?

Though compulsory licensing of pharmaceuticals in the BRICS (Brazil, Russia, India, China, and South Africa) is quite commonplace, Russia has historically bucked that trend. However, facing some diseases in epidemic proportions and with the high cost of therapies – especially those for HIV/AIDS and Hepatitis C – 2016 may be a turning point in Russian […]

Are Narrow Networks the key to telemedicine growth?

While we keep hearing telemedicine is the future of healthcare and ready to register exponential growth at any moment, advocates are still waiting for that one unifying factor that could push it to the mainstream. That factor could be the advent of accountable care networks. As the healthcare industry continues to move away from fee-for-service […]

Oil and Healthcare: Oil Prices Create Havoc in the Land of Soccer and Samba

Until recently, Brazil – like many other oil producing countries – benefited from high oil prices, experiencing years of economic growth and prosperity. However, in the two years since oil prices began falling in 2014, much has changed. 2016 should be a year of celebration in Brazil, which will be hosting the 31st Summer Olympics; […]

More exchanges with a lone insurer on tap for 2017

Despite a few outliers, most state exchange markets have avoided the stigma of only offering plans from a single insurer. That will change in 2017, although it might say less about the Affordable Care Act’s success or failure than the staying power of those markets’ historic compositions. While the many rural counties nationwide have faced […]

Interventional Oncology – here come the big guns

One of the fastest-growing and most dynamic markets covered by the medtech team here at DRG is the field of interventional oncology. Although both ablation devices (used to a heat, cool or even electrocute tumor tissue in order to destroy it) and embolization particles (used to plug up vessels feeding tumors, in order to control […]

Digital health news update: Merger mania; advertising’s existential dillema

Walgreens is expanding its telehealth deal with MDLive to cover behavioral therapy virtual visits as part of a broader mental health offering. Fortune notes that it “gives Walgreens an important touchpoint with payers, providers and patients: drug adherence.” Fitbit CEO James Park told investors and analysts that the company is looking to go deeper on […]

Latin America scrambles to contain Zika virus

From relative obscurity, the Zika virus burst into global consciousness in early 2016 as the arbovirus spread rapidly across the Latin American region and threatens to hit the United States. In its wake, the Zika virus is leaving countries scrambling to stop it before more people become infected, with particular focus on pregnant women. Although […]

War on Cancer: A Unified Battle in the 21st Century

Nearly half a century after the inception of the National Cancer Act in 1971 and U.S. President Nixon’s declaration of “war on cancer” great progress in understanding cancer biology, developing new therapeutics and diagnostics, and improving patient access has been made; however, the incidence of cancer has been rising and efforts to reduce overall cancer […]

The Decision Resources Group Companies Are Now DRG

Introducing the new DRG Since its inception, Decision Resources Group (DRG) has been a premier provider of healthcare analytics, data, and insight products and services to the world’s leading pharma, biotech, and med tech companies. In an increasingly competitive and dynamic healthcare marketplace, the ability to access, synthesize and analyze data can make or break […]

Medical devices for the everyday consumer: in more places than you’d think

The medical device industry is pretty elusive?most people go about their everyday lives without really thinking about this industry churning away in the background. In fact, you might not have even thought of your hip implant or pacemaker being a cog in a much larger wheel of a very important industry. While big pharma is …